CD274 and breast carcinoma: In this context, we have recently addressed the possibility that PD-L1 carry out broader pro-metastatic activities than immune suppression, and explored the ability of PD-L1 to induce cell-autonomous pro-metastatic phenotypes and functions in TNBC and luminal A breast cancer cells.